-
ScaleMatrix’ DDC Technology Enables Enterprises to Deploy 13 PFLOP NVIDIA DGX-powered ‘AI Anywhere’ Infrastructure with Flexible, ‘No Data Center Required’ Design
Nov 18, 2019, 19:24 PM by Michael CroftDENVER, CO - Nov 18, 2019 - ScaleMatrix, through its subsidiary company, DDC, the global leader in providing scalable data center-to-edge solutions based on its patented Dynamic Density Control™ (DDC) cabinet technology, today announced that it is collaborating with NVIDIA and Microway to deliver SKUs for an 8 petaFLOPS and a 13 petaFLOPS 'Supercomputer Anywhere' solution using its DDC S-Series cabinetsxFull story -
Greenphire Demonstrates Continued Commitment to Global Sponsors and Sites; Participates in Two Leading European Clinical Trial Conferences and Hosts User Group in Poland
Nov 18, 2019, 13:29 PM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Nov 18, 2019 - Greenphire, the global leader in financial workflow automation solutions for clinical trials, today announced its company executives will present at two of Europe's most important clinical trial conferences, the Central & Eastern European Site Symposium in Warsaw, Poland on Monday, November 18 and Clinical Trials Europe, in Barcelona, Spain on Thursday, November 21Full story -
Life Image and Graticule Launch GLIMPS in the New AWS Data Exchange
Nov 18, 2019, 12:50 PM by Michael CroftNEWTON, MA, UNITED STATES - Nov 18, 2019 - Life Image, one of the worlds largest medical evidence networks for clinical and imaging data, and its strategic partner, Graticule, an advanced real world data firm, announced the availability of GLIMPS (Graticule Life Image Machine Parsed Set) data licensing subscriptions in AWS Data Exchange, a new service that makes it easy for millions of Amazon Web Services (AWS) customers to securely find, subscribe to, and use third-party data in the cloudFull story -
TOP500 Supercomputers List Announced
Nov 18, 2019, 12:06 PM by Michael CroftTOP500 | The 54th edition of the TOP500 saw China and the US maintaining their dominance of the list, albeit in different categories.Full story -
Reducing Wasted Life Science Research By Using Factorial Experiments
Nov 18, 2019, 10:30 AM by Michael CroftFull storyBio-IT World Contributed Commentary | To combat the waste of life science research, Sridhar Iyengar advocates building comprehensive lab monitoring and information systems that, using "AI", can "correlate fluctuations in many different variables" to deviations in observed results. There is, however, another completely different approach to tease out from the "myriad factors": factorial experimentation, in particular, 2-level screening experiments.
-
Montrium Releases Office 365 Compliance Toolkits to Accelerate Transition to Cloud for the Life Sciences
Nov 18, 2019, 07:56 AM by Michael CroftMONTREAL, QC, CANADA - Nov 20, 2019 - Montrium, an experienced and trusted technology consulting company for the life sciences industry, today announced the launch of a series of comprehensive service Toolkits to support migrating and managing regulated content in Microsofts Office 365 platformFull story -
Survey Findings Show Increase in Clinical Trial Results Transparency
Nov 15, 2019, 11:46 AM by Michael CroftJERSEY CITY, NJ, UNITED STATES - Nov 15, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has released results from its 2nd Biennial Plain Language Summaries (PLS) SurveyFull story -
Lifebit and Medley Genomics Partner to Deliver Streamlined Solution Supporting New Diagnostic and Therapeutic Discoveries
Nov 14, 2019, 08:13 AM by Michael CroftLONDON, UK - Nov 14, 2019 -Full story
Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, and Medley Genomics, a company focused on using advanced data analytics to support better diagnosis and treatment of complex diseases, announced today their partnership agreement -
Oxford Nanopore Develops Pore-C, Couples Chromatin Conformation Capture With Long Read Tech
Nov 14, 2019, 07:45 AM by Michael CroftFull storyBio-IT World News Brief | Last week Weill Cornell Medicine and Oxford Nanopore published a pre-print describing Pore-C, a new nanopore sequencing technique which couples chromatin conformation capture with Oxford Nanopore Technologies long reads to directly sequence multi-way chromatin contacts without amplification.
-
Creative Diagnostics Introduces New Foodborne Pathogen Antibodies and Antigens
Nov 14, 2019, 03:21 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Nov 14, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics launches a large range of foodborne pathogen antibodies and antigens, which have been validated to work in various types of immunoassays and can be supplied as high quality tools for the detection of foodborne pathogensFull story -
MeMed Wins €2.5M Award from European Innovation Council
Nov 13, 2019, 14:58 PM by Michael CroftHAIFA, ISRAEL - Nov 13, 2019 - MeMed Ltd., a leader in host response-based diagnostic solutions, today announced that it has received €2Full story -
Baystate Health and Life Image Announce Strategic Partnership to Develop AI Innovations to Improve Treatment Decisions and Match Cancer Patients to Clinical Trials
Nov 13, 2019, 11:09 AM by Michael CroftBOSTON & SPRINGFIELD, MA, UNITED STATES - Nov 12, 2019 - Baystate Health, the premier integrated health system serving more than 800,000 patients in western New England, announced a strategic partnership with Life Image, the largest medical evidence network providing access to points of care and curated clinical and imaging data, to develop novel artificial intelligence tools that would help advance technical innovations in radiology, neurology and oncologyFull story -
LG Chem Life Sciences Expands Partnership with Avacta Group plc
Nov 13, 2019, 10:32 AM by Michael CroftCAMBRIDGE, UK, UNITED KINGDOM - Nov 13, 2019 - Avacta Group plc (AIM:AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to provide an update on the Affimer therapeutics development partnership and license agreement with LG Chem Life Sciences (LG Chem), part of the South Korean LG Group, to develop Affimer therapeutics in several disease areasFull story -
Turbine secures €3 million EUR seed fund to expand the potential of simulation-first drug discovery
Nov 13, 2019, 10:30 AM by Michael CroftLONDON, UK & BUDAPEST, HUNGARY - Nov 13, 2019 - Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin VenturesFull story -
Tumor Organoids For High-Throughput Drug Screening
Nov 13, 2019, 07:20 AM by Michael CroftFull storyBio-IT World | Interest is growing among oncology researchers in using tumor organoids to mimic cancer characteristics and drug responses in humans.
-
X4 Pharmaceuticals Receives Breakthrough Therapy Designation from the FDA for Mavorixafor for the Treatment of WHIM Syndrome
Nov 12, 2019, 09:35 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Nov 12, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the UFull story -
Lifebit Announces General Release of its Federated Genomics Cloud Operating System
Nov 8, 2019, 10:53 AM by Michael CroftLONDON, UK - Nov 7, 2019 - Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, announced today the general release of Lifebit CloudOSFull story -
OptraHEALTH, InformedDNA Partner To Expand Access To Genetics Experts
Nov 8, 2019, 09:20 AM by Michael CroftFull storyBio-IT World News Brief | OptraHEALTH and InformedDNA today announced that they will partner to offer access to InformedDNA’s board-certified genetic counselors through GeneFAX’s AI-enabled CounselorConnect platform.
-
UKI2S wins Best Sector Support Organisation at the OBN Awards
Nov 8, 2019, 05:51 AM by Michael CroftLONDON, UK - Nov 8, 2019 - UK Innovation & Science Seed Fund (UKI2S) is delighted to announce it is has been awarded Best Sector Support Organisation at the 11th Annual OBN Awards celebration last nightFull story -
Signant Health Host 8th Annual eCOA Forum To Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology
Nov 7, 2019, 11:42 AM by Michael CroftPHILADELPHIA, PA - Nov 7, 2019 - Signant Health is proud to host its 8th annual eCOA Forum, which convenes clinical operations and outcomes research leaders for the industry’s premier event focused on eCOA, eConsent, and patient-centric technologyFull story